by Commetric | Mar 10, 2023
Our analysis of the media debate around the demonised tobacco industry found that companies’ efforts to reposition themselves as health brands were met with significant backlash and inflicted additional harm to their reputation. We suggest that tobacco PR and...
by Commetric | Oct 14, 2021
For a long time, the media debate around Alzheimer’s has been dominated by news of failed clinical trials – giants such as Merck, Eli Lilly and Pfizer, as well as lesser-known companies like Axovant and Prana Biotech, have all announced...
by Commetric | Aug 13, 2021
While pharma companies experienced reputational boosts thanks to the rapid vaccine development, they are now facing increasing pressure to introduce new Covid treatments, as more and more experts assert that vaccination alone won’t be enough to handle the...
by Commetric | Aug 6, 2021
The media continues to be ruthless towards Big Tobacco, as governments present new regulations and NGOs voice even graver concerns about the dangers of smoking. However, the recent media discussion has focused on how several tobacco companies aim to reposition...
by Commetric | Jul 23, 2021
The pandemic put mRNA in the media spotlight, with many stories reporting that the novel technology could be used beyond Covid. Our analysis found that mRNA’s success seen with Pfizer and Moderna has started to change the conversation around diseases such as...
